MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.730
+0.140 (8.81%)
At close: Sep 18, 2026, 4:00 PM EDT
1.720
-0.010 (-0.58%)
After-hours: Sep 18, 2026, 7:30 PM EDT
MetaVia Employees
MetaVia had 8 employees as of December 31, 2025. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,805,750
Market Cap
11.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | -1 | -11.11% |
| Dec 31, 2024 | 9 | 1 | 12.50% |
| Dec 31, 2023 | 8 | 6 | 300.00% |
| Dec 31, 2022 | 2 | -3 | -60.00% |
| Dec 31, 2021 | 5 | -2 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Vistagen Therapeutics | 41 |
| Lunai Bioworks | 29 |
| BioLineRx | 24 |
| IN8bio | 18 |
| Theriva Biologics | 16 |
| FibroBiologics | 15 |
| Azitra | 13 |
MTVA News
- 10 days ago - MetaVia reports results from DA-1726-derived radioactivity study - TheFly
- 10 days ago - MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction - PRNewsWire
- 6 weeks ago - MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 6 weeks ago - MetaVia Earnings release: Q2 2026 - Filings
- 6 weeks ago - MetaVia Quarterly report: Q2 2026 - Filings
- 6 weeks ago - MetaVia Slides: Investor presentation - Filings
- 2 months ago - MetaVia announces completion of dose titration in Phase 1 study of DA-1726 - TheFly
- 2 months ago - MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity - PRNewsWire